Effects of the treatment with IFNβ and GM-CSF-secreting CT2A cells to wildtype CT2A tumor microenvironment post resection

To elucidate the underlying immune responses elicited by IFNβ and GM-CSF-secreting CT2A cells to brain tumor microenvironment post resection compared to placebo group and non-IFNβ and GM-CSF-secreting CT2A cell group Comparative gene expression profiling analysis of RNA-seq data for tumor tissues harvested from mouse brains post-resection and treatment with either sECM only, GFP-TCs (control cells), and ThTCs (IFNβ and GM-CSF-secreting cells).